Monoclonal antibody production is one of the most thriving branches of the pharmaceutical industry. The enhanced interest in antibody production is due to the success of antibody treatments which are used to trigger an immune response against infe...
The development and manufacturing of monoclonal antibodies represent fundamental processes in the production of several biologics, and require dedicated solutions to be carried out. As it is a highly complex procedure where much can go wrong, labo...
Handling monoclonal antibodies safely can be quite a challenge for biopharmaceutical manufacturers. mAb production is a sensitive process, prone to contamination risks that can easily lead to product alterations and product loss.1 To protect staff...
Monoclonal antibodies have kickstarted a new era in diagnostics, therapy, and research and continue to show great potential for use in medicine and science. In this article, we explore the steps that collectively lead to the creation of these b...
There are several challenges to overcome in order to make monoclonal antibody production a success. However, biopharma companies have to be prepared to face them all, as mAbs are an extremely requested product and heavily used in biotechnology: Se...
Monoclonal antibodies (mAbs) stand at the forefront of revolutionary medical advancements, playing an important role in diverse therapies and biopharmaceutical breakthroughs. The significance of these engineered proteins extends beyond traditio...
The growing request for monoclonal antibodies in scientific research and clinical applications also results in the need for professional aseptic filling solutions for mAb manufacturing. Be it in cancer therapy or the treatment of autoimmune dis...
Antibody storage stands as a linchpin in safeguarding their quality: It is to ensure the cold chain across scientific research and diagnostics as well as the efficacy and safety of their clinical applications. The integrity of these essential prot...
The monoclonal antibody production process is the igniting spark in the manufacturing of countless biologics. These specialized agents have reshaped treatment methodologies, diagnostic possibilities, and research approaches. However, producing mon...
Scaling up monoclonal antibody (mAb) production is the pressing challenge faced by many in biopharma today. The need to meet the surging demand for these crucial therapies drives an urgent search for practical, effective solutions. In this arti...
Monoclonal antibodies are specialized proteins generated in laboratories, revolutionizing healthcare treatments. They target specific cells or pathogens, offering precise therapies for conditions like cancer and infectious diseases. In this articl...
Monoclonal antibody production is shaped by changing trends and continuous scientific progress. The increasing need for high-quality mAbs for more and more applications require manufacturers to permanently improve production processes. However, it...
